BIESF
Price
$32.00
Change
+$1.52 (+4.99%)
Updated
Mar 10 closing price
Capitalization
1.6B
MLYS
Price
$13.46
Change
+$0.05 (+0.37%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
877.26M
6 days until earnings call
Interact to see
Advertisement

BIESF vs MLYS

Header iconBIESF vs MLYS Comparison
Open Charts BIESF vs MLYSBanner chart's image
Biotest AG
Price$32.00
Change+$1.52 (+4.99%)
Volume$100
Capitalization1.6B
Mineralys Therapeutics
Price$13.46
Change+$0.05 (+0.37%)
Volume$3.47K
Capitalization877.26M
BIESF vs MLYS Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIESF vs. MLYS commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIESF is a StrongBuy and MLYS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (BIESF: $32.00 vs. MLYS: $13.41)
Brand notoriety: BIESF and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIESF: 100% vs. MLYS: 78%
Market capitalization -- BIESF: $1.6B vs. MLYS: $874M
BIESF [@Biotechnology] is valued at $1.6B. MLYS’s [@Biotechnology] market capitalization is $874M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIESF’s FA Score shows that 1 FA rating(s) are green whileMLYS’s FA Score has 1 green FA rating(s).

  • BIESF’s FA Score: 1 green, 4 red.
  • MLYS’s FA Score: 1 green, 4 red.
According to our system of comparison, BIESF is a better buy in the long-term than MLYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 4 TA indicator(s) are bullish.

  • MLYS’s TA Score: 4 bullish, 4 bearish.

Price Growth

BIESF (@Biotechnology) experienced а 0.00% price change this week, while MLYS (@Biotechnology) price change was -3.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIESF($1.6B) has a higher market cap than MLYS($877M). MLYS YTD gains are higher at: 8.936 vs. BIESF (4.987). BIESF has higher annual earnings (EBITDA): 88.9M vs. MLYS (-201.44M). MLYS has more cash in the bank: 343M vs. BIESF (37.8M). BIESF has higher revenues than MLYS: BIESF (707M) vs MLYS (0).
BIESFMLYSBIESF / MLYS
Capitalization1.6B877M182%
EBITDA88.9M-201.44M-44%
Gain YTD4.9878.93656%
P/E Ratio43.70N/A-
Revenue707M0-
Total Cash37.8M343M11%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BIESF: Fundamental Ratings
BIESF
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIESFMLYS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
5%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
6%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.810.18
+0.80%
GameStop Corp
TSLA308.72-0.54
-0.17%
Tesla
AAPL202.92-0.43
-0.21%
Apple
SPY627.97-3.20
-0.51%
SPDR® S&P 500® ETF
BTC.X114141.445000-930.437500
-0.81%
Bitcoin cryptocurrency

BIESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIESF has been closely correlated with BSFAF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIESF jumps, then BSFAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIESF
1D Price
Change %
BIESF100%
N/A
BSFAF - BIESF
82%
Closely correlated
N/A
PTGX - BIESF
68%
Closely correlated
+0.13%
MLYS - BIESF
45%
Loosely correlated
+2.92%
TRVI - BIESF
43%
Loosely correlated
-1.07%
SOLTF - BIESF
35%
Loosely correlated
+0.32%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+2.92%
PTGX - MLYS
50%
Loosely correlated
+0.13%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
39%
Loosely correlated
-1.44%
APGE - MLYS
36%
Loosely correlated
+2.93%
ACLX - MLYS
35%
Loosely correlated
-0.06%
More